Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Corden Pharma Acquires Roche Site | Contract Pharma

What are you searching for?

Sign in
Breaking News

Corden Pharma Acquires Roche Site

ICIG division to supply API from Colorado facility

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

International Chemical Investors Group (ICIG) has entered into an agreement for to acquire Roche Colorado Corp., which includes Roche’s pharmaceutical production facility in Boulder, CO. The acquisition covers approximately 265 employees and includes technical development and small molecule manufacturing capabilities. Financial terms were not disclosed.

ICIG plans to operate the Boulder site as Corden Pharma Colorado Inc., a component of its Corden Pharma organization; it will initially supply Roche with a number of API that the Boulder site currently produces.

“Selling the Boulder site to ICIG will secure a reliable supplier to meet Roche’s demand for commercial scale peptides and other medicinal compounds,” said Dr. Georg Wiebecke, the head of Chemical Manufacturing for Roche. “We also are pleased to identify a buyer that will create a sustainable future for the Boulder site.”

According to an ICIG statement, Roche’s Boulder facility is “a global leader in the production of therapeutic peptide compounds, having pioneered large scale synthetic manufacturing technologies.” The site also maintains capabilities in the production of complex small molecules and highly potent compounds.

“By purchasing the Boulder facility, we position ourselves for a commanding presence in the contract peptide manufacturing industry,” said Dr. Wolfgang Niedermaier, the president of Corden Pharma. “We are excited to expand the market for the Boulder site’s unique technical capabilities, attracting additional API production opportunities that will build on its existing portfolio of Roche products and other pharmaceutical contract business.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics